Smokers and single men are more likely to acquire cancer-causing oral human papillomavirus (HPV), according to new results from the HPV Infection in Men (HIM) Study. Also, newly acquired oral HPV infections in healthy men are rare and, when present, usually resolve within 1 year.
HPV infection is known to cause virtually all cervical cancers, most anal cancers, and some genital cancers. It has recently been established as a cause of the majority of oropharyngeal cancers, which are a malignancy of the tonsils and the base of the tongue.
HPV-related oropharyngeal cancer is rare, but rates have been increasing rapidly, especially among men. To determine the pattern of HPV acquisition and persistence in the oral region, researchers evaluated the HPV infection status in oral mouthwash samples collected as part of the HIM Study, which was originally designed to evaluate the natural history of genital HPV infections in healthy men.
“Some types of HPV, such as HPV16, are known to cause cancer at multiple places in the body, including the oral cavity,” said lead author Christine M. Pierce Campbell, PhD, MPH, a postdoctoral fellow at the Moffitt Cancer Center in Tampa, Florida. “We know that HPV infection is associated with oropharyngeal cancer, but we don’t know how the virus progresses from initial infection to cancer in the oral cavity. One aspect of the HIM Study is to gather data to help us understand the natural history of these infections.”
During the first 12 months, nearly 4.5% of men in the study acquired an oral HPV infection. Less than 1% of men in the study had an HPV16 infection, the most commonly acquired type, and less than 2% had a cancer-causing type of oral HPV. The study was published in The Lancet (2013; doi:10.1016/S0140-6736(13)60809-0).
Their findings are consistent with previous studies showing a low prevalence of oral HPV cancers. However, this study shows the acquisition of cancer-causing oral HPV appeared greater among smokers and unmarried men.
“Additional HPV natural history studies are needed to better inform the development of infection-related prevention efforts,” said senior author Anna R. Giuliano, PhD, also of Moffitt. “HPV16 is associated with the rapid increase in incidence of oropharyngeal cancer, most noticeably in the United States, Sweden, and Australia, where it is responsible for more than 50% of cases. Unfortunately, there are no proven methods to prevent or detect these cancers at an early stage.”
The researchers note that persistent oral HPV16 infection may be a precursor to oropharyngeal cancer, similar to how persistent cervical HPV infection leads to cervical precancer.